SALL4 and hepatocellular carcinoma: The analysis showed HCC patients with high SALL4 serum levels had worse prognosis than patients with low serum SALL4 expression (P = 0.013) (as shown in Figure 3), which means HCC patients with low serum concentration of SALL4 protein had a better prognosis.